Tango Therapeutics (TNGX) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Tango Therapeutics (TNGX) over the last 5 years, with Q3 2025 value amounting to $0.13.
- Tango Therapeutics' EPS (Weighted Average and Diluted) rose 14814.81% to $0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.92, marking a year-over-year increase of 2068.97%. This contributed to the annual value of -$1.19 for FY2024, which is 1088.63% down from last year.
- Per Tango Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at $0.13 for Q3 2025, which was up 14814.81% from -$0.35 recorded in Q2 2025.
- Over the past 5 years, Tango Therapeutics' EPS (Weighted Average and Diluted) peaked at $0.13 during Q3 2025, and registered a low of -$0.36 during Q1 2025.
- Over the past 5 years, Tango Therapeutics' median EPS (Weighted Average and Diluted) value was -$0.3 (recorded in 2022), while the average stood at -$0.27.
- In the last 5 years, Tango Therapeutics' EPS (Weighted Average and Diluted) crashed by 21111.11% in 2022 and then soared by 14814.81% in 2025.
- Quarter analysis of 5 years shows Tango Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.36 in 2021, then rose by 7.07% to -$0.33 in 2022, then grew by 1.47% to -$0.33 in 2023, then decreased by 5.95% to -$0.34 in 2024, then skyrocketed by 137.74% to $0.13 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.13 in Q3 2025, compared to -$0.35 in Q2 2025 and -$0.36 in Q1 2025.